Cart
sales@molnova.com
5-Chlorovaleronitrile
CAS No. 6280-87-1
5-Chlorovaleronitrile( AI3-20151 | AI3 20151 | AI320151 )
Catalog No. M27271 CAS No. 6280-87-1
5-Chlorovaleronitrile can be used as a quantitative structure-toxicity model to predict the aquatic toxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 29 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 63 | In Stock |
|
| 100MG | 96 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 216 | In Stock |
|
| 1G | 319 | In Stock |
|
Biological Information
-
Product Name5-Chlorovaleronitrile
-
NoteResearch use only, not for human use.
-
Brief Description5-Chlorovaleronitrile can be used as a quantitative structure-toxicity model to predict the aquatic toxicity.
-
Description5-Chlorovaleronitrile can be used as a quantitative structure-toxicity model to predict the aquatic toxicity.
-
In Vitro——
-
In Vivo——
-
SynonymsAI3-20151 | AI3 20151 | AI320151
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6280-87-1
-
Formula Weight117.58
-
Molecular FormulaC5H8ClN
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClCCCCC#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Christopher LJ, et, al. Metabolism and disposition of dasatinib after oral administration to humans. Drug Metab Dispos. 2008 Jul;36(7):1357-64.
molnova catalog
related products
-
Salvianolic acid D
Salvianolic acid D and notoginseng triterpenes can promote EA-hy926 and expression of protein with protective effects on angiogenesis in EA-hy926 cells in vitro.
-
FM04
FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2).
-
Tenuifoliside A
Tenuifoliside A has anti-apoptotic, neuroprotective activity. And tenuifoliside A has anti-inflammatory effect, which is mediated by the inhibition of the NF-κB and MAPK pathways.
